SIGN UP
LOG IN
Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Benzinga·03/26/2025 09:00:09
Listen to the news
Shares of GameStop Corp. (NYSE:GME) rose sharply in today's pre-market trading after reporting better-than-expected fourth-quarter earnings.
GameStop reported fourth-quarter revenue of $1.283 billion, missing the consensus estimate of $1.48 billion. The video game retailer reported fourth-quarter adjusted earnings of 30 cents per share, beating analyst estimates of eight cents per share, according to Benzinga Pro.
GameStop shares jumped 13.4% to $28.79 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
- Theratechnologies Inc. (NASDAQ:THTX) gained 88.3% to $2.9100 in pre-market trading after the company received FDA approval for EGRIFTA WR™ (Tesamorelin F8) to treat excess visceral abdominal fat in adults with HIV and Lipodystrophy.
- SurgePays, Inc. (NASDAQ:SURG) gained 69.5% to $2.34 in pre-market trading after the company reported better-than-expected FY24 sales results.
- Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) rose 64.4% to $0.0950 in pre-market trading after dipping over 18% on Tuesday.
- AquaBounty Technologies, Inc. (NASDAQ:AQB) gained 37.2% to $0.9280 in pre-market trading after gaining 19% on Tuesday.
- CISO Global Inc. (NASDAQ:CISO) rose 22.4% to $0.5511 in pre-market trading after the company said it paid off its highest-interest loans as part of its ongoing efforts to strengthen its balance sheet.
- China Liberal Education Holdings Limited (NASDAQ:CLEU) gained 17.7% to $2.330 in pre-market trading after falling 6% on Tuesday.
- TherapeuticsMD, Inc. (NASDAQ:TXMD) gained 15.3% to $1.05 in pre-market trading after gaining 5% on Tuesday.
- Windtree Therapeutics, Inc. (NASDAQ:WINT) rose 12.8% to $1.85 in pre-market trading. Windtree Therapeutics recently announced it regained compliance status with Nasdaq regarding its listing rule standards.
- Bon Natural Life Limited (NASDAQ:BON) gained 9.4% to $0.1728 in pre-market.
Losers
- Golden Heaven Group Holdings Ltd. (NASDAQ:GDHG) fell 24.4% to $2.88 in pre-market trading after jumping 94% on Tuesday.
- Humacyte, Inc. (NASDAQ:HUMA) shares fell 22.1% to $2.24 in pre-market trading after the company priced its $50 million public offering of 25 million common stock at $2.00 per share.
- Integrated Media Technology Limited (NASDAQ:IMTE) shares tumbled 17.5% to $1.56 in pre-market trading after dipping 10% on Tuesday.
- SAG Holdings Limited (NASDAQ:SAG) declined 16.6% to $0.8503 in pre-market trading after jumping 32% on Tuesday.
- Benson Hill, Inc. (NASDAQ:BHIL) fell 16.1% to $0.3552 in pre-market trading after the company received Court approval of first-day motions to support ongoing operations during Chapter 11 process.
- BioSig Technologies, Inc. (NASDAQ:BSGM) dipped 14.7% to $0.45 in pre-market trading after gaining 7% on Tuesday.
- Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) shares dipped 14.6% to $7.00 in pre-market trading after gaining 41% on Tuesday.
- Nyxoah S.A. (NASDAQ:NYXH) fell 11.8% to $9.99 in today's pre-market trading. The FDA issued Nyxoah an approvable letter for its Genio® system.
- Rapport Therapeutics, Inc. (NASDAQ:RAPP) fell 9.5% to $9.10 in pre-market trading.
- Oruka Therapeutics, Inc. (NASDAQ:ORKA) shares fell 5% to $11.40 in pre-market trading.
Now Read This:
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.